- Home
- Publications
- Publication Search
- Publication Details
Title
Ebola virus vaccines – reality or fiction?
Authors
Keywords
-
Journal
Expert Review of Vaccines
Volume 15, Issue 11, Pages 1421-1430
Publisher
Informa UK Limited
Online
2016-04-15
DOI
10.1080/14760584.2016.1178068
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Use of ChAd3-EBO-Z Ebola virus vaccine in Malian and US adults, and boosting of Malian adults with MVA-BN-Filo: a phase 1, single-blind, randomised trial, a phase 1b, open-label and double-blind, dose-escalation trial, and a nested, randomised, double-blind, placebo-controlled trial
- (2016) Milagritos D Tapia et al. LANCET INFECTIOUS DISEASES
- Safety and immunogenicity of a chimpanzee adenovirus-vectored Ebola vaccine in healthy adults: a randomised, double-blind, placebo-controlled, dose-finding, phase 1/2a study
- (2016) Olga De Santis et al. LANCET INFECTIOUS DISEASES
- Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe
- (2016) Selidji T. Agnandji et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cytomegalovirus-based vaccine expressing Ebola virus glycoprotein protects nonhuman primates from Ebola virus infection
- (2016) Andrea Marzi et al. Scientific Reports
- Aerosolized Ebola vaccine protects primates and elicits lung-resident T cell responses
- (2015) Michelle Meyer et al. JOURNAL OF CLINICAL INVESTIGATION
- Preclinical Development of Inactivated Rabies Virus–Based Polyvalent Vaccine Against Rabies and Filoviruses
- (2015) Mallory Willet et al. JOURNAL OF INFECTIOUS DISEASES
- Modeling the Disease Course ofZaire ebolavirusInfection in the Outbred Guinea Pig
- (2015) Robert W. Cross et al. JOURNAL OF INFECTIOUS DISEASES
- Considerations in the Use of Nonhuman Primate Models of Ebola Virus and Marburg Virus Infection: Table 1.
- (2015) Thomas W. Geisbert et al. JOURNAL OF INFECTIOUS DISEASES
- Safety and immunogenicity of Ebola virus and Marburg virus glycoprotein DNA vaccines assessed separately and concomitantly in healthy Ugandan adults: a phase 1b, randomised, double-blind, placebo-controlled clinical trial
- (2015) Hannah Kibuuka et al. LANCET
- Safety and immunogenicity of a novel recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in China: preliminary report of a randomised, double-blind, placebo-controlled, phase 1 trial
- (2015) Feng-Cai Zhu et al. LANCET
- Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial
- (2015) Ana Maria Henao-Restrepo et al. LANCET
- The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trial
- (2015) Angela Huttner et al. LANCET INFECTIOUS DISEASES
- Chimpanzee Adenovirus Vector Ebola Vaccine — Preliminary Report
- (2015) NEW ENGLAND JOURNAL OF MEDICINE
- An Ebola whole-virus vaccine is protective in nonhuman primates
- (2015) A. Marzi et al. SCIENCE
- VSV-EBOV rapidly protects macaques against infection with the 2014/15 Ebola virus outbreak strain
- (2015) A. Marzi et al. SCIENCE
- Ebola Virus Infections in Nonhuman Primates Are Temporally Influenced by Glycoprotein Poly-U Editing Site Populations in the Exposure Material
- (2015) John Trefry et al. Viruses-Basel
- Experimental Inoculation of Egyptian Rousette Bats (Rousettus aegyptiacus) with Viruses of the Ebolavirus and Marburgvirus Genera
- (2015) Megan Jones et al. Viruses-Basel
- Codon-optimized filovirus DNA vaccines delivered by intramuscular electroporation protect cynomolgus macaques from lethal Ebola and Marburg virus challenges
- (2015) Rebecca J Grant-Klein et al. Human Vaccines & Immunotherapeutics
- Homologous and Heterologous Protection of Nonhuman Primates by Ebola and Sudan Virus-Like Particles
- (2015) Kelly L. Warfield et al. PLoS One
- Safety and Immunogenicity of DNA Vaccines Encoding Ebolavirus and Marburgvirus Wild-Type Glycoproteins in a Phase I Clinical Trial
- (2014) U. N. Sarwar et al. JOURNAL OF INFECTIOUS DISEASES
- Chimpanzee adenovirus vaccine generates acute and durable protective immunity against ebolavirus challenge
- (2014) Daphne A Stanley et al. NATURE MEDICINE
- Vaccinating captive chimpanzees to save wild chimpanzees
- (2014) K. L. Warfield et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Immunization with vesicular stomatitis virus vaccine expressing the Ebola glycoprotein provides sustained long-term protection in rodents
- (2014) Gary Wong et al. VACCINE
- Challenges, Progress, and Opportunities: Proceedings of the Filovirus Medical Countermeasures Workshop
- (2014) Rona Hirschberg et al. Viruses-Basel
- Venezuelan Equine Encephalitis Virus Replicon Particle Vaccine Protects Nonhuman Primates from Intramuscular and Aerosol Challenge with Ebolavirus
- (2013) A. S. Herbert et al. JOURNAL OF VIROLOGY
- Airway Delivery of an Adenovirus-Based Ebola Virus Vaccine Bypasses Existing Immunity to Homologous Adenovirus in Nonhuman Primates
- (2013) J. S. Richardson et al. JOURNAL OF VIROLOGY
- Antibodies are necessary for rVSV/ZEBOV-GP-mediated protection against lethal Ebola virus challenge in nonhuman primates
- (2013) A. Marzi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Vaccines for viral hemorrhagic fevers—progress and shortcomings
- (2013) Darryl Falzarano et al. Current Opinion in Virology
- Vesicular Stomatitis Virus-Based Vaccines Protect Nonhuman Primates against Bundibugyo ebolavirus
- (2013) Chad E. Mire et al. PLoS Neglected Tropical Diseases
- Antibody Quality and Protection from Lethal Ebola Virus Challenge in Nonhuman Primates Immunized with Rabies Virus Based Bivalent Vaccine
- (2013) Joseph E. Blaney et al. PLoS Pathogens
- A Syrian Golden Hamster Model Recapitulating Ebola Hemorrhagic Fever
- (2012) Hideki Ebihara et al. JOURNAL OF INFECTIOUS DISEASES
- Human Papillomavirus Vaccines – Immune Responses
- (2012) Margaret Stanley et al. VACCINE
- Recombinant Vesicular Stomatitis Virus Vaccine Vectors Expressing Filovirus Glycoproteins Lack Neurovirulence in Nonhuman Primates
- (2012) Chad E. Mire et al. PLoS Neglected Tropical Diseases
- Impact of Systemic or Mucosal Immunity to Adenovirus on Ad-Based Ebola Virus Vaccine Efficacy in Guinea Pigs
- (2011) Jason S. Richardson et al. JOURNAL OF INFECTIOUS DISEASES
- Advances in Virus-Like Particle Vaccines for Filoviruses
- (2011) Kelly L. Warfield et al. JOURNAL OF INFECTIOUS DISEASES
- Vesicular Stomatitis Virus–Based Ebola Vaccines With Improved Cross-Protective Efficacy
- (2011) Andrea Marzi et al. JOURNAL OF INFECTIOUS DISEASES
- A New Ebola Virus Nonstructural Glycoprotein Expressed through RNA Editing
- (2011) M. Mehedi et al. JOURNAL OF VIROLOGY
- Recombinant Adenovirus Serotype 26 (Ad26) and Ad35 Vaccine Vectors Bypass Immunity to Ad5 and Protect Nonhuman Primates against Ebolavirus Challenge
- (2011) T. W. Geisbert et al. JOURNAL OF VIROLOGY
- Inactivated or Live-Attenuated Bivalent Vaccines That Confer Protection against Rabies and Ebola Viruses
- (2011) J. E. Blaney et al. JOURNAL OF VIROLOGY
- A Single Sublingual Dose of an Adenovirus-Based Vaccine Protects against Lethal Ebola Challenge in Mice and Guinea Pigs
- (2011) Jin Huk Choi et al. MOLECULAR PHARMACEUTICS
- A replication defective recombinant Ad5 vaccine expressing Ebola virus GP is safe and immunogenic in healthy adults
- (2010) J.E. Ledgerwood et al. VACCINE
- Mucosal parainfluenza virus-vectored vaccine against Ebola virus replicates in the respiratory tract of vector-immune monkeys and is immunogenic
- (2010) Alexander A. Bukreyev et al. VIROLOGY
- Demonstration of Cross-Protective Vaccine Immunity against an Emerging Pathogenic Ebolavirus Species
- (2010) Lisa E. Hensley et al. PLoS Pathogens
- Development and Characterization of a Mouse Model for Marburg Hemorrhagic Fever
- (2009) K. L. Warfield et al. JOURNAL OF VIROLOGY
- Single-Injection Vaccine Protects Nonhuman Primates against Infection with Marburg Virus and Three Species of Ebola Virus
- (2009) T. W. Geisbert et al. JOURNAL OF VIROLOGY
- Correlates of protective immunity for Ebola vaccines: implications for regulatory approval by the animal rule
- (2009) Nancy J. Sullivan et al. NATURE REVIEWS MICROBIOLOGY
- Mucosal Immunization of Cynomolgus Macaques with the VSVΔG/ZEBOVGP Vaccine Stimulates Strong Ebola GP-Specific Immune Responses
- (2009) Xiangguo Qiu et al. PLoS One
- International epidemiology of human pre-existing adenovirus (Ad) type-5, type-6, type-26 and type-36 neutralizing antibodies: Correlates of high Ad5 titers and implications for potential HIV vaccine trials
- (2009) T. Christopher Mast et al. VACCINE
- Current progress of DNA vaccine studies in humans
- (2008) Shan Lu et al. Expert Review of Vaccines
- Nasal Delivery of an Adenovirus-Based Vaccine Bypasses Pre-Existing Immunity to the Vaccine Carrier and Improves the Immune Response in Mice
- (2008) Maria A. Croyle et al. PLoS One
- Generation of biologically contained Ebola viruses
- (2008) P. Halfmann et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Vesicular stomatitis virus-based vaccines protect nonhuman primates against aerosol challenge with Ebola and Marburg viruses
- (2008) Thomas W. Geisbert et al. VACCINE
- Vesicular Stomatitis Virus-Based Ebola Vaccine Is Well-Tolerated and Protects Immunocompromised Nonhuman Primates
- (2008) Thomas W. Geisbert et al. PLoS Pathogens
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More